Frequency assessment of β-lactamase enzymes in Escherichia coli and Klebsiella isolates in patients with urinary tract infection

Journal of Research in Medical Sciences

Volumn 19, Issue SPEC. ISSUE, 2014, Pages

  Moayednia, Reza ^a   Shokri, Dariush ^b   Mobasherizadeh, Sina ^c   Baradaran, Azar ^a   Fatemi, Seyed Masih ^d   Merrikhi, Alireza ^e  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Department of Pediatric Infectious Diseases Infectious Diseases and Tropical Medicine Research Center   (Iran)

^c Nosocomial Infection Research Center Shahrekord Branch   (Iran)

^d ISLAMIC AZAD UNIVERSITY   (Iran)

^e ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antibiotic resistance; Carbapenem drugs; Extended spectrum lactamase; Klebsiella pneumoniae carbapenemase; Metallo lactamase; Urinary tract infection

Indexed keywords

AMIKACIN; AMPICILLIN; BETA LACTAMASE; CARBAPENEMASE; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; NITROFURANTOIN; PIPERACILLIN PLUS TAZOBACTAM;

AGAR DIFFUSION; ANTIBIOTIC SENSITIVITY; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISK DIFFUSION; ESCHERICHIA COLI; FEMALE; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; KLEBSIELLA; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; PHENOTYPE; PREVALENCE; URINARY TRACT INFECTION;

EID: 84900323947     PISSN: 17351995     EISSN: 17357136     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Tzelepi E, Magana Ch, Platsouka E, Sofianou D, Paniara O, Legakis NJ, et al. Extended-spectrum beta-lactamase types in Klebsiella pneumoniae and Escherichia coli in two Greek hospitals. Int J Antimicrob Agents 2003;21:285-8.
2. Hirakata Y, Matsuda J, Miyazaki Y, Kamihira S, Kawakami S, Miyazawa Y, et al. Regional variation in the prevalence of extendedspectrum beta-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002). Diagn Microbiol Infect Dis 2005;52:323-9.
3. Rupp ME, Fey PD. Extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae: Considerations for diagnosis, prevention and drug treatment. Drugs 2003;63:353-65.
4. Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: A clinical update. Clin Microbiol Rev 2005;18:657-86.
5. Livermore DM, Canton R, Gniadkowski M, Nordmann P, Rossolini GM, Arlet G, et al. CTX-M: Changing the face of ESBLs in Europe. J Antimicrob Chemother 2007;59:165-74.
6. st century: Characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001;14:933-51.
7. Sundsfjord A, Simonsen GS, Haldorsen BC, Haaheim H, Hjelmevoll SO, Littauer P, et al. Genetic methods for detection of antimicrobial resistance. APMIS 2004;112:815-37.
8. Zagorianou A, Sianou E, Iosifidis E, Dimou V, Protonotariou E, Miyakis S, et al. Microbiological and molecular characteristics of carbapenemase-producing Klebsiella pneumoniae endemic in a tertiary Greek hospital during 2004-2010. Euro Surveill 2012;17:20088.
9. Cornaglia G, Akova M, Amicosante G, Cantón R, Cauda R, Docquier JD, et al. Metallo-beta-lactamases as emerging resistance determinants in Gram-negative pathogens: Open issues. Int J Antimicrob Agents 2007;29:380-8.
10. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Disk Susceptibility Tests. Approved Standard M2-A9. Wayne, PA: Clinical and Laboratory Standards Institute; 2013.
11. Mobasherizadeh S, Shokri D, Zargarzadeh AH, Jalalpour S, Ebneshahidi SA, Sajadi M. Antimicrobial resistance surveillance among hospitalized and non-hospitalized extend-spectrum betalactamase producing Escherichia coli from four tertiary-care hospitals in Isfahan, Iran; 2008-2011. Afr J Microbiol Res 2012;6:953-9.
12. Centers for Disease Control and Prevention. Modified Hodge test for carbapenemase detection in Enterobacteriaceae. Atlanta: Centers for Disease Control and Prevention (CDC); 2007.
13. Oliver A, Coque TM, Alonso D, Valverde A, Baquero F, Cantón R. CTX-M-10 linked to a phage-related element is widely disseminated among Enterobacteriaceae in a Spanish hospital. Antimicrob Agents Chemother 2005;49:1567-71.
14. Jacoby GA, Medeiros AA. More extended-spectrum beta-lactamases. Antimicrob Agents Chemother 1991;35:1697-704.
15. Brun-Buisson C, Legrand P, Philippon A, Montravers F, Ansquer M, Duval J. Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae. Lancet 1987;2:302-6.
16. Wiener J, Quinn JP, Bradford PA, Goering RV, Nathan C, Bush K, et al. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 1999;281:517-23.
17. Ghorbani A, Ehsanpour A, Roshanzamir N, Omidvar B. Alterations in antibiotic susceptibility of urinary tract infection pathogens. J Nephropathol 2012;1:43-8.
18. Kalantar E. Minimizing potential resistance among bacteria causing urinary tract infection. J Nephropathol 2012;1:11-2.
19. Seifi Z, Azish M, Salehi Z, Zarei Mahmoudabadi A, Shamsizadeh A. Candiduria in children and susceptibility patterns of recovered Candida species to antifungal drugs in Ahvaz. J Nephropathol 2013;2:122-8.
20. Ardalan MR. Mycobacterial disease in renal allograft recipients. J Ren Inj Prev 2013;2:83-4.
21. Turner PJ. Extended spectrum beta lactamases. Clin Infect Dis 2005;41:73-5.
22. Pai H. The characteristics of extended-spectrum beta-lactamases in Korean isolates of Enterobacteriaceae. Yonsei Med J 1998;39:514-9.
23. Kawakami S, Ono Y, Yamamoto M, Matumura M, Okamoto R, Inoue M, et al. Extended-spectrum beta-lactamase (ESBL) produced by Escherichia coli and Klebsiella pneumoniae isolated from Teikyou University Hospital - The first report. Kansenshogaku Zasshi 1999;73:1110-5.
24. Hawkey PM. Prevalence and clonality of extended-spectrum betalactamases in Asia. Clin Microbiol Infect 2008;14 Suppl 1:159-65.
25. Jabeen K, Zafar A, Hasan R. Frequency and sensitivity pattern of extended spectrum beta lactamase producing isolates in a tertiary care hospital laboratory of Pakistan. J Pak Med Assoc 2005;55:436-9.
26. Mehrgan H, Rahbar M. Prevalence of extended-spectrum betalactamase- producing Escherichia coli in a tertiary care hospital in Tehran, Iran. Int J Antimicrob Agents 2008;31:147-51.
27. Mirsalehian A, Akbari-Nakhjavani F, Peymani A, Kazemi B, Jabal Ameli F, Mirafshar SM. Prevalence of extended spectrum β-lactamase producing Enterobacteriaceae by phenotypic and genotypic methods in intensive care units in Tehran, Iran. Daru 2008;16:169-73.
28. Mirsalehian A, Nakhjavani F, Peymani A, Jabal Ameli F, Mirafshar SM, Hamidian M. Frequency of extended spectrum β-lactamase producing Enterobacteriaceae in intensive care units. Tehran Univ Med J 2007;65:33-8.
29. Walsh TR, Toleman MA, Poirel L, Nordmann P. Metallo-betalactamases: The quiet before the storm? Clin Microbiol Rev 2005;18:306-25.
30. Deshpande LM, Rhomberg PR, Sader HS, Jones RN. Emergence of serine carbapenemases (KPC and SME) among clinical strains of Enterobacteriaceae isolated in the United States Medical Centers: Report from the MYSTIC Program (1999-2005). Diagn Microbiol Infect Dis 2006;56:367-72.
31. Bratu S, Tolaney P, Karumudi U, Quale J, Mooty M, Nichani S, et al. Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: Molecular epidemiology and in vitro activity of polymyxin B and other agents. J Antimicrob Chemother 2005;56:128-32.